Visiting Fellow in Bioethics, Ethics & Public Policy Center
Alexander Raikin is a Visiting Fellow in the Bioethics, Technology and Human Flourishing Program at the Ethics and Public Policy Center. His research focuses on the dignity of human life and end-of-life issues, especially on its impact on the field of medicine and broader ethical questions of social belonging.
For tips, please send an email to araikin+tips@eppc.org.
His writing has been widely cited in major publications such as The Atlantic and the New York Times and in academic journals in the United States, Canada, UK, and France. He wrote cover stories for National Review and The New Atlantis, while his other bylines include City Journal, Plough, and the Washington Free Beacon. Raikin frequently speaks on national radio and on major podcasts.
Last year, Raikin was an inaugural Richard John Neuhaus Fellow at the Public Interest Fellowship and EPPC. He was a Tikvah Summer Fellow and a Killam scholar with Fulbright at American University. He graduated from Carleton University with a bachelor’s degree in public policy. Raikin is a proud member of Kesher Israel synagogue and lives with his wife in Washington, D.C.
Senior Fellow, Cato Institute
Jeffrey A. Singer is a senior fellow at the Cato Institute and works in the Department of Health Policy Studies. He is principal and founder of Valley Surgical Clinics Ltd., the largest and oldest group private surgical practice in Arizona, and has been in private practice as a general surgeon for more than 35 years.
He is also a visiting fellow at the Goldwater Institute in Phoenix. Singer is a member of the Board of Scientific Advisors of the American Council on Science and Health. From 1994 to 2016, he was a regular contributor to Arizona Medicine, the journal of the Arizona Medical Association. He served on the Advisory Board Council of the Center for Political Thought and Leadership at Arizona State University from 2014 to 2018 and is an adjunct instructor in the Program on Political History and Leadership at ASU. He writes and speaks extensively on regional and national public policy, with a specific focus on the areas of health care policy and the harmful effects of drug prohibition.
He received his BA from Brooklyn College (City University of New York) and his MD from New York Medical College. He is a fellow of the American College of Surgeons.
Managing Director, Berkeley Research Group
Dan Troy is Managing Director and an expert witness on FDA matters at Berkeley Research Group. Previously he served as Chief Counsel of the US Food and Drug Administration and General Counsel of GlaxoSmithKline PLC.
Comfort Care or Hastened Death? Assisted Suicide and the Medicare Hospice Benefit